Amgen snaps up Dark Blue for $840M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks’ 2025 highlights include biotech investments
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Limoneira closes sale of its Chilean ranches for $15M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Why Lee Cole remains a force in the avocado industry
Calavo CEO Lee Cole’s second retirement comes as the Santa Paula-based company’s board of directors is weighing a buyout offer and looking at other alternatives. It was just a few years ago that Cole, who built the modern Calavo into a world leader in distributing avocados, guacamole and fresh food distribution, stepped back into the Read More →
Calavo ponders buyout as CEO retires
Santa Paula-based Calavo Growers announced that Lee Cole will retire as president and CEO on Dec. 8 — his second retirement in five years — as the company ponders an unsolicited proposal. Announced Nov. 12, this was Cole’s second stint as CEO, as his first go-round was from 1999 until 2020, and he also served as Read More →
Amgen delivers earnings beat in Q3
Thousand Oaks-based Amgen delivered a sound third-quarter earnings beat when it announced financial results on Nov. 4, highlighting big sales beats from blockbuster drugs Repatha and Prolia. Amgen, one of the largest biotechnology companies in the world, announced that revenue for the quarter ended Sept. 30 reached $9.6 billion, a 12% year-over-year increase, driven by Read More →
Amgen seeks T.O. approval for planned $600M center
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
